Why a drug treatment for dementia has eluded us

older woman sits on bed
Pfizer has announced it will stop research into developing drugs to treat Alzheimer’s disease, after costly failed attempts over the past decade Jürgen Götz, Director, Clem Jones Centre for Ageing Dementia Research, The University of Queensland Finding a cure for neurodegenerative diseases such as Alzheimer’s is challenging. They’re difficult to diagnose, and drugs struggle to get

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pharmacist prescribing moving ahead
Next Rural, remote dwellers more vulnerable